AI-driven protein therapeutics developer moving programs toward regulatory filings
Generate:Biomedicines pairs an ML stack (PyTorch, JAX, TensorFlow) on AWS and GCP with wet-lab tooling like cryo-EM, LC-MS and HPLC, closing the loop between computational protein design and high-throughput assays. Accelerating, director-heavy hiring across clinical, safety and quality, plus Medidata Rave, SAS and NDA/BLA safety work, signals a shift from discovery toward late-stage clinical and submission readiness.
Notable leadership hires: Scientific Project Lead
Generate:Biomedicines is a privately held biotechnology company headquartered in Somerville, Massachusetts, with 201–500 employees. The company applies generative AI to design protein-based therapeutics, running computational design alongside experimental systems such as high-throughput assays and biosensors. Its engineering platform is built on Kubernetes, Terraform, Helm and Argo CD across AWS and GCP, with Python and PostgreSQL in the data layer. Clinical operations use Medidata Rave, SAS and Spotfire, and manufacturing relies on outsourced CDMO partners. Hiring is currently concentrated in the United States.
PyTorch, JAX and TensorFlow for ML; Kubernetes, Terraform, Helm, Argo CD and GitLab on AWS and GCP; PostgreSQL and Redshift for data; Medidata Rave, SAS and Spotfire for clinical work.
Yes, hiring is accelerating in the United States, weighted toward senior and director-level roles in clinical/healthcare, research, quality and engineering functions.
NDA/BLA safety strategies, next-generation high-throughput experimental systems, miniaturized pooled assays, biosensors integrated with AI design, and a risk-based GxP quality framework.
Other companies in the same industry, closest in size
Generate:Biomedicines's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.